Novo Nordisk A/s Earnings

Novo Nordisk A/s’s revenue jumped 30.09% since last year same period to $85683Mn in the Q4 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 20.15% jump in its revenue since last 3-months.

Novo Nordisk A/s’s net profit jumped 28.53% since last year same period to $28230Mn in the Q4 2024. On a quarterly growth basis, Novo Nordisk A/s has generated 3.4% jump in its net profits since last 3-months.

Novo Nordisk A/s’s net profit margin fell -1.2% since last year same period to 32.95% in the Q4 2024. On a quarterly growth basis, Novo Nordisk A/s has generated -13.94% fall in its net profit margins since last 3-months.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current quarter stand at 6.12 - a 594.89% jump from last quarter’s estimates.

Novo Nordisk A/s’s earning per share (EPS) estimates for the current year stand at 6.12.

Novo Nordisk A/s’s earning per share (EPS) jumped 792.96% since last year same period to 6.34 in the Q4 2024. This indicates that the Novo Nordisk A/s has generated 792.96% annual rate of jump in its earning per share (EPS) in the last 4 quarters.